award

Phase 2 Trial of Gamunex ( Intravenous Gammaglobulin) for Sickle Cell Acute Pain

  • Award Number: R01FD005341

  • ORGANIZATION: FOOD AND DRUG ADMINISTRATION

  • OPDIV: FDA

  • AWARD CLASS: DISCRETIONARY

  • AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

  • PERIOD OF PERFORMANCE START DATE: 09/10/2015

  • PERIOD OF PERFORMANCE END DATE: 06/30/2023